Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v25-FR | Version v10-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-03-28 | 2023-12-15 |
| Drug Identification Number | 02469405 | 02469405 |
| Brand name | PREVYMIS | PREVYMIS |
| Common or Proper name | Letermovir for injection | Letermovir for injection |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | LETERMOVIR | LETERMOVIR |
| Strength(s) | 20MG | 20MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 x Vial | 1 x Vial |
| ATC code | J05AX | J05AX |
| ATC description | DIRECT ACTING ANTIVIRALS | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2024-02-05 | 2024-01-08 |
| Actual start date | 2024-01-31 | |
| Estimated end date | 2024-04-05 | 2024-03-29 |
| Actual end date | 2024-03-27 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | PREVYMIS SFI 240MG VIAL, PREVYMIS 240MG 4X7TAB & PREVYMIS 480MG 4X7TAB formats remain available. | PREVYMIS SFI 240MG VIAL, PREVYMIS 240MG 4X7TAB & PREVYMIS 480MG 4X7TAB formats remain available. |
| Health Canada comments |